SCHEMBL22956271

SCHEMBL22956271

N#CCCc1ccc(OCC(=O)NC23CC(NCCOc4ccc(Cl)c(F)c4)(C2)C3)nc1

nearest known ligand 0.51

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ ATF4 P18848 20/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19556140 0.84 ATF4 (0.57) ATF4
SCHEMBL19556309 0.81 ATF4 (0.53) ATF4
SCHEMBL20974287 0.79 ATF4 (0.64) ATF4
SCHEMBL22396997 0.79 ATF4 (0.66) ATF4
SCHEMBL20974175 0.79 ATF4 (0.61) ATF4
SCHEMBL30025584 0.79 ATF4 (0.61) ATF4
SCHEMBL30026071 0.78 ATF4 (0.64) ATF4
SCHEMBL20973815 0.78 ATF4 (0.64) ATF4
SCHEMBL19569752 0.75 ATF4 (0.56) ATF4
SCHEMBL19569753 0.75 ATF4 (0.59) ATF4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10913727-B2 Modulators of the integrated stress pathway ABBVIE INC. (US) 2021-02-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10913727-B2 Modulators of the integrated stress pathway ATF4, ATF1, DDIT3 ATF4 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback